Partial
Mostly Aligned
Patient Risk:
Medium
Summary
The AI response aligns with ibuprofen indications and general NSAID warnings present in the supplied label, but contains multiple Lipitor-related interaction claims not supported by the provided labeling. Overall, the alignment is partial with several unsupported or not-evident statements regarding Lipitor, dosage specifics, and certain adverse interaction details.
Category Scores
Accurate Statements
Ibuprofen tablets are indicated for relief of mild to moderate pain.
INDICATIONS AND USAGE
Ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea.
INDICATIONS AND USAGE
Use the lowest effective dose for the shortest duration.
INDICATIONS AND USAGE
Controlled clinical trials to establish safety and effectiveness in children have not been conducted.
INDICATIONS AND USAGE
Renal effects warnings are present in the label (monitor for renal function during NSAID use).
WARNINGS, Renal Effects
Monitor your liver function regularly.
WARNINGS AND PRECAUTIONS
Avoid taking ibuprofen for extended periods.
INDICATIONS AND USAGE
Patients should talk to their doctor or pharmacist about the potential risks and benefits of taking ibuprofen with Lipitor.
INDICATIONS AND USAGE
Unsupported Statements
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain, reduce inflammation, and lower fever.
The label excerpt provided lists ibuprofen indications for RA, OA, mild to moderate pain, and dysmenorrhea, but does not explicitly state fever reduction.
It is available over-the-counter in 200mg, 400mg, and 600mg tablets.
No tablet strength information is provided in the supplied label sections.
There is a risk of interaction between ibuprofen and Lipitor.
The available label sections do not document a Lipitor-ibuprofen interaction.
Ibuprofen can increase the levels of Lipitor in the blood.
No data in the supplied label sections support an increase in Lipitor levels due to ibuprofen.
Increased Lipitor levels may lead to increased side effects.
No label evidence supporting Lipitor-specific interactions with ibuprofen in the provided sections.
The risk of bleeding is increased when taking ibuprofen with Lipitor.
The label's drug interaction content does not mention Lipitor; bleeding risk with NSAIDs is discussed in a broader context but not Lipitor-specific.
Ibuprofen can thin the blood.
Not specified in the provided label sections.
The risk of bleeding is increased when taking statins, including Lipitor, with NSAIDs like ibuprofen.
Not supported by the supplied label sections.
Ibuprofen can reduce blood flow to the kidneys.
Not specified in the provided label sections.
Ibuprofen can worsen kidney function in individuals taking Lipitor.
Not specified in the provided label sections.
NSAIDs, including ibuprofen, can increase the risk of kidney damage in patients taking statins.
Not specified in the provided label sections.
There is also a risk of liver damage when taking ibuprofen with Lipitor.
Liver damage risk is discussed for NSAIDs in general, but Lipitor-specific interaction is not documented in the supplied sections.
Lipitor prescribing information states that the risk of liver damage is increased when taking statins, including Lipitor, with NSAIDs like ibuprofen.
The provided label sections do not include Lipitor content; this claim is not verifiable from the supplied label.
Dr. David Juurlink states that the risk of bleeding is a significant concern when taking ibuprofen with Lipitor.
Not supported by the provided label sections.
Monitor your liver function regularly.
Repeated; considered supported in CLAIM EVALUATION, but categorized here as unsupported due to redundancy with supported statement above.
Watch for signs of bleeding, such as bruising or bleeding gums.
Not documented in the supplied label sections.
Drugs include acetaminophen, naproxen, celecoxib as alternatives with Lipitor.
Label sections do not provide Lipitor-specific alternative analgesic guidance in the supplied content; while some claims were marked as supported in CLAIM EVALUATION, they are not clearly evidenced in the provided label text.
Contradictions
Low
AI Statement
Label Reference
Important Omissions
No explicit contraindications section or formal contraindications extracted for ibuprofen from the provided label text.
Importance:
Moderate
No explicit boxed warnings provided in the ibuprofen label excerpt.
Importance:
Moderate
Limited dosing specifics (eg, mg guidance, duration limits) in the provided label text.
Importance:
Moderate
Complete Lipitor-specific interaction details with NSAIDs are not present in the supplied sections, limiting evaluation of those claims.
Importance:
High
Safety Assessment
Potential Patient Risk:
Medium
Label includes renal and hepatic warnings for NSAID use; however, several Lipitor–ibuprofen interaction claims lack label support, indicating potential risk if taken concomitantly but not clearly defined in the supplied text.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Lipitor-related interaction claims are not supported by the provided ibuprofen label content.
Suggested Improvement
Limit statements to what's explicitly supported by the label content (ibuprofen indications, warnings, interactions with listed drug classes), and avoid Lipitor-specific interaction claims unless the label explicitly documents them. Include precise dosing guidance if available in the label and reference specific sections for patient counseling regarding NSAID use with concomitant lipid-lowering therapy.